Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,413 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Onset of quiescence following p53 mediated down-regulation of H2AX in normal cells.
Atsumi Y, Fujimori H, Fukuda H, Inase A, Shinohe K, Yoshioka Y, Shikanai M, Ichijima Y, Unno J, Mizutani S, Tsuchiya N, Hippo Y, Nakagama H, Masutani M, Teraoka H, Yoshioka K. Atsumi Y, et al. Among authors: yoshioka y, yoshioka k. PLoS One. 2011;6(8):e23432. doi: 10.1371/journal.pone.0023432. Epub 2011 Aug 12. PLoS One. 2011. PMID: 21858116 Free PMC article.
Impact of tumor position displacement during end-exhalation breath-hold condition on tumor dose in lung stereotactic body radiation therapy using volumetric modulated arc therapy.
Kamima T, Moriya S, Sakae T, Miyauchi H, Ito Y, Tokumasu K, Yoshioka Y. Kamima T, et al. Among authors: yoshioka y. Clin Transl Radiat Oncol. 2025 Jan 8;51:100916. doi: 10.1016/j.ctro.2025.100916. eCollection 2025 Mar. Clin Transl Radiat Oncol. 2025. PMID: 39877300 Free PMC article.
Ageing and inflammation limit the induction of SARS-CoV-2-specific CD8+ T cell responses in severe COVID-19.
Autaa G, Papagno L, Nogimori T, Boizard-Moracchini A, Korenkov D, Roy M, Suzuki K, Masuta Y, White E, Llewellyn-Lacey S, Yoshioka Y, Nicoli F, Price DA, Dechanet-Merville J, Yamamoto T, Pellegrin I, Appay V. Autaa G, et al. Among authors: yoshioka y. JCI Insight. 2025 Jan 23:e180867. doi: 10.1172/jci.insight.180867. Online ahead of print. JCI Insight. 2025. PMID: 39847442 Free article.
Low-inflammatory lipid nanoparticle-based mRNA vaccine elicits protective immunity against H5N1 influenza virus with reduced adverse reactions.
Kawai A, Shimizu T, Tanaka H, Shichinohe S, Anindita J, Hirose M, Kawahara E, Senpuku K, Shimooka M, Quynh Mai LT, Suzuki R, Nogimori T, Yamamoto T, Hirai T, Kato T, Watanabe T, Akita H, Yoshioka Y. Kawai A, et al. Among authors: yoshioka y. Mol Ther. 2024 Dec 17:S1525-0016(24)00831-1. doi: 10.1016/j.ymthe.2024.12.032. Online ahead of print. Mol Ther. 2024. PMID: 39690742 Free article.
1,413 results